Harrison Hayes Launches Second BioArbitrage Fund
Harrison Hayes, a boutique innovation and strategy consulting firm, announced the launch of a second BioArbitrage fund. BioArbitrage involves earning a risk-free profit without the outlay of capital. Harrison Hayes is currently seeking a partner/investor for the fund.
- (1888PressRelease) March 21, 2013 - CHARLOTTE, NC - The BioArbitrage fund will identify undervalued assets that will be auctioned in the open market for immediate return. The fund will be managed by Harrison Hayes and based out of its Manhattan office.
"We have effectively overseen eight transactions with our first BioArbitrage model in the last year," said Bill Smith, Chief Executive Officer at Harrison Hayes. "As an innovation consultancy, we believe that the BioArbitrage fund is a key piece in developing an innovation pipeline."
About Harrison Hayes
Harrison Hayes is a boutique Innovation Consultancy focused on driving new revenue growth for our select clients in the life sciences. We accomplish this by forging innovation strategies, developing and ideating new products and businesses, and accelerating their path to market.
We are a highly differentiated company as we intersect the dynamics of creative product development, innovation research, and intellectual property identification.
Contacts
Harrison Hayes, LLC
Bill Smith
Chief Executive Officer
704-972-2400
wsmith ( @ ) harrisonhayes dot com
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam